metyrapone has been researched along with Cancer of Kidney in 3 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ney, RL | 1 |
| Hammond, W | 1 |
| Wright, L | 1 |
| Davis, WW | 1 |
| Acker, J | 1 |
| Bartter, FC | 1 |
| Gassel, WD | 1 |
| Gerdes, H | 1 |
| Littmann, KP | 1 |
| Koller, F | 1 |
| Thorens, B | 1 |
| Riondel, AM | 1 |
| Scholer, D | 1 |
3 other studies available for metyrapone and Cancer of Kidney
| Article | Year |
|---|---|
Studies in a patient with an ectopic adrenocortical tumor.
Topics: 17-Hydroxycorticosteroids; Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotrop | 1966 |
[Case report on a female patient with 17- -hydroxylase deficiency].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Androgen-Insensitivity Syndrome; Corticosteron | 1971 |
[Proceedings: Cushing's syndrome in hypernephroid carcinoma; normalization of the cortisol value, hypokalemia and hypertension under metopirone].
Topics: Adenocarcinoma; Cushing Syndrome; Humans; Hydrocortisone; Hypertension; Hypokalemia; Kidney Neoplasm | 1974 |